Skip Navigation

ARACOG: A Randomized Phase II Study of Androgen Receptor Directed Therapy on COGnitive Function in Patients Treated with Darolutamide or Enzalutamide

Brief Summary

Type:
Prostate

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT04335682

Study #:
STUDY00145897

Start Date:
Dec 06, 2021

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT04335682

View Complete Trial Details & Eligibility at ClinicalTrials.gov